Pengda Zhai Xueliang Niu Kai Zheng
10.3389/fonc.2022.915628
Front Oncol
2022 Jul 11;12:915628.
high pd-l1 expression induction therapy lung cancer toripalimab uncommon epidermal growth factor receptor mutation
CC BY
https://pubmed.ncbi.nlm.nih.gov/35898897/
Case Reports
PMC9309724
35898897
A Dramatic Response to Toripalimab With Chemotherapy and Antiangiogenic Agent Followed by Surgery in a Stage IIIB Lung Adenocarcinoma Patient With an Uncommon EGFR Mutation: A Case Report
2022